Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 235 articles:
HTML format



Single Articles


    November 2021
  1. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427458. doi: 10.1093.
    PubMed     Abstract available


  2. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


  3. DELORY T, Le Bel J, Lariven S, Peiffer-Smadja N, et al
    Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423107. doi: 10.1093.
    PubMed     Abstract available


  4. LIEPA R, Mann R, Osman M, Hamze M, et al
    Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain.
    J Antimicrob Chemother. 2021 Nov 6. pii: 6422573. doi: 10.1093.
    PubMed     Abstract available


  5. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    PubMed    


    October 2021
  6. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


  7. GUILLOTEAU H, Pradalier C, Roman VL, Bellanger X, et al
    Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay.
    J Antimicrob Chemother. 2021 Oct 21. pii: 6407543. doi: 10.1093.
    PubMed     Abstract available


  8. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Oct 20. pii: 6403927. doi: 10.1093.
    PubMed     Abstract available


  9. HE YZ, Kuang X, Long TF, Li G, et al
    Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    J Antimicrob Chemother. 2021 Oct 6. pii: 6382243. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  10. BARRAUD O, Guichard E, Chainier D, Postil D, et al
    Integrons, a predictive biomarker for antibiotic resistance in acute sepsis: the IRIS study.
    J Antimicrob Chemother. 2021 Sep 24. pii: 6374797. doi: 10.1093.
    PubMed     Abstract available


  11. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    PubMed     Abstract available


  12. AMBROSE SJ, Hall RM
    Origin of the dfrA44 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371308. doi: 10.1093.
    PubMed    


  13. BANGALEE A, Hans L, Steegen K
    Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    J Antimicrob Chemother. 2021;76:2659-2665.
    PubMed     Abstract available


  14. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  15. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  16. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  17. GILL CM, Abdelraouf K, Oota M, Nakamura R, et al
    Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
    J Antimicrob Chemother. 2021;76:2615-2621.
    PubMed     Abstract available


  18. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    PubMed    


  19. TOMCZYK S, Taylor A, Brown A, de Kraker MEA, et al
    Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362680. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  20. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  21. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  22. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    PubMed     Abstract available


  23. HISCOX JA, Khoo SH, Stewart JP, Owen A, et al
    Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
    J Antimicrob Chemother. 2021;76:2230-2233.
    PubMed     Abstract available


  24. ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
    Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
    J Antimicrob Chemother. 2021;76:2394-2399.
    PubMed     Abstract available


  25. MARTIN C, Gracias S, Charpentier C, Descamps D, et al
    HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
    J Antimicrob Chemother. 2021;76:2306-2309.
    PubMed     Abstract available


  26. TAYLOR E, Bal AM, Balakrishnan I, Brown NM, et al
    A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.
    J Antimicrob Chemother. 2021;76:2428-2436.
    PubMed     Abstract available


  27. MARCELIN AG, Charpentier C, Bellecave P, Abdi B, et al
    Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
    J Antimicrob Chemother. 2021;76:2400-2406.
    PubMed     Abstract available


  28. WATERA C, Ssemwanga D, Namayanja G, Asio J, et al
    HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    J Antimicrob Chemother. 2021;76:2407-2414.
    PubMed     Abstract available


  29. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  30. WICKRAMAGE I, Spigaglia P, Sun X
    Mechanisms of antibiotic resistance of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327067. doi: 10.1093.
    PubMed     Abstract available


  31. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  32. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.
    J Antimicrob Chemother. 2021;76:2061-2070.
    PubMed     Abstract available


  33. MILLIERE L, Bocket L, Tinez C, Robineau O, et al
    Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.
    J Antimicrob Chemother. 2021;76:2143-2147.
    PubMed     Abstract available


  34. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  35. BRENNER BG, Oliveira M, Ibanescu RI, Routy JP, et al
    Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.
    J Antimicrob Chemother. 2021;76:2137-2142.
    PubMed     Abstract available


  36. BIGGEL M, Zurfluh K, Treier A, Nuesch-Inderbinen M, et al
    Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples.
    J Antimicrob Chemother. 2021;76:2004-2011.
    PubMed     Abstract available


    June 2021
  37. AMBROSE SJ, Hall RM
    dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering.
    J Antimicrob Chemother. 2021 Jun 28. pii: 6310424. doi: 10.1093.
    PubMed     Abstract available


  38. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  39. LU HF, Tsai YC, Li LH, Lin YT, et al
    Role of AzoR, a LysR-type transcriptional regulator, in SmeVWX pump-mediated antibiotic resistance in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307154. doi: 10.1093.
    PubMed     Abstract available


  40. ZINNER SH, Alieva KN, Golikova MV, Strukova EN, et al
    Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
    J Antimicrob Chemother. 2021;76:1832-1839.
    PubMed     Abstract available


  41. HORNER C, Mushtaq S, Allen M, Longshaw C, et al
    Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
    J Antimicrob Chemother. 2021;76:1822-1831.
    PubMed     Abstract available


  42. LAUMEN JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, et al
    Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2021;76:1752-1758.
    PubMed     Abstract available


  43. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  44. JIMENEZ DE ORY S, Beltran-Pavez C, Gutierrez-Lopez M, Santos MDM, et al
    Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure.
    J Antimicrob Chemother. 2021;76:1886-1892.
    PubMed     Abstract available


  45. GISKE CG, Kahlmeter G, MacGowan A, Turnidge J, et al
    Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study.
    J Antimicrob Chemother. 2021;76:1949-1950.
    PubMed    


  46. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Erratum to: Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Jun 14. pii: 6298302. doi: 10.1093.
    PubMed    


    May 2021
  47. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  48. ABDI B, Chebbi M, Wirden M, Teyssou E, et al
    No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
    J Antimicrob Chemother. 2021;76:1553-1557.
    PubMed     Abstract available


  49. LI JZ, Stella N, Choudhary MC, Javed A, et al
    Impact of pre-existing drug resistance on risk of virological failure in South Africa.
    J Antimicrob Chemother. 2021;76:1558-1563.
    PubMed     Abstract available


  50. MERNISSI T, Bodeau S, Andre C, Zahr N, et al
    An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.
    J Antimicrob Chemother. 2021;76:1643-1646.
    PubMed    


  51. YADAV K, Garoff L, Huseby DL, Hughes D, et al
    Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2021;76:1441-1447.
    PubMed     Abstract available


  52. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  53. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  54. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  55. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  56. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  57. TRUSWELL A, Abraham R, O'Dea M, Lee ZZ, et al
    Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance.
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248215. doi: 10.1093.
    PubMed     Abstract available


  58. RAOULT D, Hadjadj L, Baron SA, Rolain JM, et al
    Role of glyphosate in the emergence of antimicrobial resistance in bacteria?
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248211. doi: 10.1093.
    PubMed     Abstract available


  59. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  60. AMBROSE SJ, Hall RM
    Identification of the dfrA4 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226985. doi: 10.1093.
    PubMed    


  61. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  62. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  63. DELAUGERRE C, Nere ML, Eymard-Duvernay S, Armero A, et al
    Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
    J Antimicrob Chemother. 2021;76:1286-1293.
    PubMed     Abstract available


  64. BROWN JA, Amstutz A, Nsakala BL, Seeburg U, et al
    Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    J Antimicrob Chemother. 2021;76:1294-1298.
    PubMed     Abstract available


  65. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  66. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  67. FELICIO MR, Silveira GGOS, Oshiro KGN, Meneguetti BT, et al
    Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2021;76:1174-1186.
    PubMed     Abstract available


  68. SEMENGUE ENJ, Armenia D, Inzaule S, Santoro MM, et al
    Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    J Antimicrob Chemother. 2021;76:1277-1285.
    PubMed     Abstract available


  69. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  70. MASHE T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, et al
    Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019.
    J Antimicrob Chemother. 2021;76:1160-1167.
    PubMed     Abstract available


  71. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  72. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  73. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  74. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  75. ALVAREZ-MARIN R, Lopez-Cerero L, Guerrero-Sanchez F, Palop-Borras B, et al
    Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
    J Antimicrob Chemother. 2021 Mar 26. pii: 6189039. doi: 10.1093.
    PubMed     Abstract available


  76. LUCASSEN K, Muller C, Wille J, Xanthopoulou K, et al
    Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184842. doi: 10.1093.
    PubMed     Abstract available


  77. MUSHTAQ S, Garello P, Vickers A, Woodford N, et al
    Activity of cefepime/zidebactam (WCK 5222) against 'problem' antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184840. doi: 10.1093.
    PubMed     Abstract available


  78. LI R, Peng K, Xiao X, Liu Y, et al
    Emergence of a multidrug resistance efflux pump with carbapenem resistance gene blaVIM-2 in a Pseudomonas putida megaplasmid of migratory bird origin.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184583. doi: 10.1093.
    PubMed     Abstract available


  79. HUANG HH, Wu BK, Li LH, Lin YT, et al
    Role of the PhoPQ two-component regulatory system in the beta-lactam resistance of Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Mar 19. pii: 6178648. doi: 10.1093.
    PubMed     Abstract available


  80. KRAGH KN, Gijon D, Maruri A, Antonelli A, et al
    Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
    J Antimicrob Chemother. 2021;76:1001-1009.
    PubMed     Abstract available


  81. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  82. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  83. ENGONE-ONDO JD, Mouinga-Ondeme A, Lekana-Douki SE, Diane A, et al
    High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy.
    J Antimicrob Chemother. 2021;76:1051-1056.
    PubMed     Abstract available


  84. JONES JC, Pascua PNQ, Harrington WN, Webby RJ, et al
    Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.
    J Antimicrob Chemother. 2021;76:957-960.
    PubMed     Abstract available


  85. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


    February 2021
  86. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.
    PubMed    


  87. PORTAL E, Descours G, Ginevra C, Mentasti M, et al
    Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
    J Antimicrob Chemother. 2021 Feb 20. pii: 6145330. doi: 10.1093.
    PubMed     Abstract available


  88. BROWN NM, Brown EM
    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
    J Antimicrob Chemother. 2021 Feb 14. pii: 6134889. doi: 10.1093.
    PubMed     Abstract available


  89. SALMERON P, Vinado B, Arando M, Alcoceba E, et al
    Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
    J Antimicrob Chemother. 2021 Feb 11. pii: 6132746. doi: 10.1093.
    PubMed     Abstract available


  90. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  91. KAO SW, Liu ZH, Wu TS, Ku SW, et al
    Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    J Antimicrob Chemother. 2021;76:722-728.
    PubMed     Abstract available


  92. BUTLER DA, Rana AP, Krapp F, Patel SR, et al
    Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    J Antimicrob Chemother. 2021;76:671-679.
    PubMed     Abstract available


  93. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  94. PHAM HT, Alves BM, Yoo S, Xiao MA, et al
    Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.
    J Antimicrob Chemother. 2021;76:639-647.
    PubMed     Abstract available


  95. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


  96. LE ROY C, Touati A, Balcon C, Garraud J, et al
    Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
    J Antimicrob Chemother. 2021 Feb 4. pii: 6127604. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  97. TEMKIN E, Margalit I, Nutman A, Carmeli Y, et al
    Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  98. LIU H, Moran RA, Chen Y, Doughty EL, et al
    Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids.
    J Antimicrob Chemother. 2021 Jan 27. pii: 6121227. doi: 10.1093.
    PubMed     Abstract available


  99. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  100. MACHUCA J, Recacha E, Gallego-Mesa B, Diaz-Diaz S, et al
    Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:338-344.
    PubMed     Abstract available


  101. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  102. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  103. HAMIDIAN M, Ambrose SJ, Blackwell GA, Nigro SJ, et al
    An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8 Acinetobacter baumannii isolates at a Sydney hospital.
    J Antimicrob Chemother. 2021 Jan 16. pii: 6102239. doi: 10.1093.
    PubMed     Abstract available


  104. SWEENEY EL, Lowry K, Bletchly C, Nimmo GR, et al
    Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.
    J Antimicrob Chemother. 2021 Jan 15. pii: 6100778. doi: 10.1093.
    PubMed     Abstract available


  105. GOLPARIAN D, Sanchez-Buso L, Cole M, Unemo M, et al
    Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
    J Antimicrob Chemother. 2021 Jan 7. pii: 6067623. doi: 10.1093.
    PubMed     Abstract available


  106. MUSHTAQ S, Vickers A, Doumith M, Ellington MJ, et al
    Activity of beta-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria.
    J Antimicrob Chemother. 2021;76:160-170.
    PubMed     Abstract available


  107. MARTIN E, Philbin M, Hughes G, Bergin C, et al
    Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.
    J Antimicrob Chemother. 2021;76:272-275.
    PubMed    


  108. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  109. HUA X, Moran RA, Xu Q, He J, et al
    Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2021;76:65-69.
    PubMed     Abstract available


  110. CHERNY SS, Nevo D, Baraz A, Baruch S, et al
    Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling.
    J Antimicrob Chemother. 2021;76:239-248.
    PubMed     Abstract available


  111. SALADINI F, Giammarino F, Hosseini BA, Giannini A, et al
    In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
    J Antimicrob Chemother. 2021;76:130-134.
    PubMed     Abstract available


  112. WENK BM, Mbunkah HA, Nsanwe NN, Mbu ET, et al
    Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
    J Antimicrob Chemother. 2021;76:124-129.
    PubMed     Abstract available


    December 2020
  113. XANTHOPOULOU K, Wille J, Zweigner J, Lucassen K, et al
    Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
    J Antimicrob Chemother. 2020 Dec 28. pii: 6054276. doi: 10.1093.
    PubMed     Abstract available


  114. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


  115. PEZZANI MD, Mazzaferri F, Compri M, Galia L, et al
    Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  116. MIRANDA C, Silva V, Capita R, Alonso-Calleja C, et al
    Implications of antibiotics use during the COVID-19 pandemic: present and future.
    J Antimicrob Chemother. 2020;75:3413-3416.
    PubMed     Abstract available


    November 2020
  117. ZHU Y, Wang C, Schwarz S, Liu W, et al
    Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Nov 28. pii: 6008797. doi: 10.1093.
    PubMed     Abstract available


  118. YUSEF D, Hayajneh WA, Bani Issa A, Haddad R, et al
    Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan.
    J Antimicrob Chemother. 2020 Nov 21. pii: 5997451. doi: 10.1093.
    PubMed     Abstract available


  119. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


  120. SHROPSHIRE WC, Aitken SL, Pifer R, Kim J, et al
    IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
    J Antimicrob Chemother. 2020 Nov 9. pii: 5961599. doi: 10.1093.
    PubMed     Abstract available


  121. MAGALLON A, Roussel M, Neuwirth C, Tetu J, et al
    Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN.
    J Antimicrob Chemother. 2020 Nov 6. pii: 5959825. doi: 10.1093.
    PubMed     Abstract available


  122. OOI N, Lee VE, Chalam-Judge N, Newman R, et al
    Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-beta-lactamases in carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957246. doi: 10.1093.
    PubMed     Abstract available


  123. HAYAJNEH WA, Al-Azzam S, Yusef D, Lattyak WJ, et al
    Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957247. doi: 10.1093.
    PubMed     Abstract available


  124. NOBREGA DB, Tang KL, Caffrey NP, De Buck J, et al
    Prevalence of antimicrobial resistance genes and its association with restricted antimicrobial use in food-producing animals: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2020 Nov 4. pii: 5955902. doi: 10.1093.
    PubMed     Abstract available


  125. COMBER SDW, Upton M, Lewin S, Powell N, et al
    COVID-19, antibiotics and One Health: a UK environmental risk assessment.
    J Antimicrob Chemother. 2020;75:3411-3412.
    PubMed    


    October 2020
  126. TKADLEC J, Capek V, Brajerova M, Smelikova E, et al
    The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942696. doi: 10.1093.
    PubMed     Abstract available


  127. FERNANDEZ JE, Perreten V, Schwendener S
    The novel macrolide resistance genes mef(F) and msr(G) are located on a plasmid in Macrococcus canis and a transposon in Macrococcus caseolyticus.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942709. doi: 10.1093.
    PubMed     Abstract available


  128. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed     Abstract available


  129. LEGER A, Lambraki I, Graells T, Cousins M, et al
    AMR-Intervene: a social-ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective.
    J Antimicrob Chemother. 2020 Oct 14. pii: 5923757. doi: 10.1093.
    PubMed     Abstract available


  130. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed     Abstract available


  131. JOHANSSON MHK, Bortolaia V, Tansirichaiya S, Aarestrup FM, et al
    Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder.
    J Antimicrob Chemother. 2020 Oct 3. pii: 5917579. doi: 10.1093.
    PubMed     Abstract available


  132. HOBSON CA, Cointe A, Bidet P, Poupon J, et al
    Urine zinc concentrations allow proper expression of metallo-beta-lactamases in Enterobacteriaceae.
    J Antimicrob Chemother. 2020;75:3077-3079.
    PubMed    


  133. PAPATHANAKOS G, Andrianopoulos I, Papathanasiou A, Koulenti D, et al
    Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions.
    J Antimicrob Chemother. 2020;75:3081.
    PubMed    


    September 2020
  134. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed     Abstract available


  135. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed     Abstract available


  136. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed    


  137. TREBOSC V, Schellhorn B, Schill J, Lucchini V, et al
    In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms.
    J Antimicrob Chemother. 2020 Sep 1. pii: 5899886. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  138. LIAO CH, Chen WC, Li LH, Lin YT, et al
    AmpR of Stenotrophomonas maltophilia is involved in stenobactin synthesis and enhanced beta-lactam resistance in an iron-depleted condition.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899264. doi: 10.1093.
    PubMed     Abstract available


  139. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed     Abstract available


  140. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed     Abstract available


  141. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed     Abstract available


  142. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed     Abstract available


  143. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed     Abstract available


  144. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  145. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed     Abstract available


  146. RODRIGUEZ-RUBIO L, Serna C, Ares-Arroyo M, Matamoros BR, et al
    Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages.
    J Antimicrob Chemother. 2020 Jul 28. pii: 5876565. doi: 10.1093.
    PubMed     Abstract available


  147. XANTHOPOULOU K, Peter S, Tobys D, Behnke M, et al
    Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology.
    J Antimicrob Chemother. 2020 Jul 22. pii: 5875232. doi: 10.1093.
    PubMed     Abstract available


  148. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed     Abstract available


  149. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed     Abstract available


  150. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed     Abstract available


  151. MAHFOUZ N, Ferreira I, Beisken S, von Haeseler A, et al
    Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review.
    J Antimicrob Chemother. 2020 Jul 13. pii: 5870983. doi: 10.1093.
    PubMed     Abstract available


  152. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed     Abstract available


  153. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed     Abstract available


  154. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  155. SATO T, Wada T, Shinagawa M, Fukushima Y, et al
    Emergence of vancomycin- and teicoplanin-resistant Enterococcus faecium via vanD5-harbouring large genomic island.
    J Antimicrob Chemother. 2020 Jun 25. pii: 5862743. doi: 10.1093.
    PubMed     Abstract available


  156. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed     Abstract available


  157. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  158. SAVOLDI A, Carrara E, Tacconelli E
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response.
    J Antimicrob Chemother. 2020 May 27. pii: 5847827. doi: 10.1093.
    PubMed    


  159. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  160. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed     Abstract available


  161. MUGGEO A, Cambau E, Amara M, Micaelo M, et al
    Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance.
    J Antimicrob Chemother. 2020 May 22. pii: 5842234. doi: 10.1093.
    PubMed     Abstract available


  162. RAWSON TM, Moore LSP, Castro-Sanchez E, Charani E, et al
    COVID-19 and the potential long-term impact on antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 20. pii: 5841159. doi: 10.1093.
    PubMed     Abstract available


  163. ORTIZ-PADILLA M, Diaz-Diaz S, Machuca J, Tejada-Gonzalez A, et al
    Role of low-level quinolone resistance in generating tolerance in Escherichia coli under therapeutic concentrations of ciprofloxacin.
    J Antimicrob Chemother. 2020 May 19. pii: 5836071. doi: 10.1093.
    PubMed     Abstract available


  164. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  165. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  166. EICHEL V, Klein S, Bootsveld C, Frank U, et al
    Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
    J Antimicrob Chemother. 2020 May 15. pii: 5837672. doi: 10.1093.
    PubMed     Abstract available


  167. VAN GAALEN RD, Altorf-van der Kuil W, Wegdam-Blans MCA, Aguilar Diaz JM, et al
    Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.
    J Antimicrob Chemother. 2020 May 14. pii: 5837067. doi: 10.1093.
    PubMed     Abstract available


  168. LI LH, Wu CM, Lin YT, Pan SY, et al
    Roles of FadRACB system in formaldehyde detoxification, oxidative stress alleviation and antibiotic susceptibility in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2020 May 14. pii: 5837066. doi: 10.1093.
    PubMed     Abstract available


  169. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  170. MANOHARAN A, Das T, Whiteley GS, Glasbey T, et al
    The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2020 May 3. pii: 5828489. doi: 10.1093.
    PubMed     Abstract available


  171. DELORY T, Jeanmougin P, Lariven S, Aubert JP, et al
    A computerized decision support system (CDSS) for antibiotic prescription in primary care-Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 1. pii: 5827803. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  172. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


  173. TORUMKUNEY D, Tunger A, Sancak B, Bicakcigil A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  174. TORUMKUNEY D, Van PH, Thinh LQ, Koo SH, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  175. TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  176. TORUMKUNEY D, Hammami A, Mezghani Maalej S, Ayed NB, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-18 in Tunisia, Kenya and Morocco: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  177. TORUMKUNEY D, Anwar S, Nizamuddin S, Malik N, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  178. TORUMKUNEY D, Smayevsky J, Relloso MS, Sucari A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  179. TORUMKUNEY D, Mokaddas E, Jiman-Fatani A, Ageel A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


    March 2020
  180. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  181. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  182. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  183. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  184. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


  185. LIM JM, Singh SR, Duong MC, Legido-Quigley H, et al
    Impact of national interventions to promote responsible antibiotic use: a systematic review.
    J Antimicrob Chemother. 2020;75:14-29.
    PubMed     Abstract available


  186. VISSEAUX B, Assoumou L, Mahjoub N, Grude M, et al
    Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
    J Antimicrob Chemother. 2020;75:183-193.
    PubMed     Abstract available


  187. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  188. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  189. TZOU PL, Rhee SY, Descamps D, Clutter DS, et al
    Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    J Antimicrob Chemother. 2020;75:170-182.
    PubMed     Abstract available


  190. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  191. RODRIGUEZ-VILLODRES A, Gil-Marques ML, Alvarez-Marin R, Bonnin RA, et al
    Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.
    J Antimicrob Chemother. 2020;75:77-85.
    PubMed     Abstract available


  192. MODICA S, Redi D, Gagliardini R, Giombini E, et al
    Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
    J Antimicrob Chemother. 2020;75:194-199.
    PubMed     Abstract available


  193. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  194. DORTET L, Broda A, Bernabeu S, Glupczynski Y, et al
    Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
    J Antimicrob Chemother. 2020;75:110-116.
    PubMed     Abstract available


  195. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  196. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  197. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  198. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  199. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  200. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  201. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  202. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  203. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


  204. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  205. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  206. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  207. WARDENBURG KE, Potter RF, D'Souza AW, Hussain T, et al
    Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.
    J Antimicrob Chemother. 2019 Aug 23. pii: 5553751. doi: 10.1093.
    PubMed     Abstract available


  208. BOJANG A, Baines SL, Donovan L, Guerillot R, et al
    Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin.
    J Antimicrob Chemother. 2019 Aug 19. pii: 5551401. doi: 10.1093.
    PubMed     Abstract available


  209. FULLER J, Dingle TC, Bull A, Shokoples S, et al
    Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    July 2019
  210. KLARE I, Bender JK, Fleige C, Kriebel N, et al
    Comparison of VITEK(R) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
    J Antimicrob Chemother. 2019 Jul 23. pii: 5537362. doi: 10.1093.
    PubMed     Abstract available


  211. SHANG Y, Li D, Hao W, Schwarz S, et al
    A prophage and two ICESa2603-family integrative and conjugative elements (ICEs) carrying optrA in Streptococcus suis.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533309. doi: 10.1093.
    PubMed     Abstract available


  212. PI R, Liu Q, Jiang Q, Gao Q, et al
    Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS.
    J Antimicrob Chemother. 2019;74:1795-1798.
    PubMed     Abstract available


  213. GONZALEZ-LARA MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, et al
    Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    J Antimicrob Chemother. 2019;74:2047-2050.
    PubMed     Abstract available


    June 2019
  214. ELGHAIEB H, Freitas AR, Abbassi MS, Novais C, et al
    Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523711. doi: 10.1093.
    PubMed     Abstract available


  215. RESENDIZ-SHARPE A, Mercier T, Lestrade PPA, van der Beek MT, et al
    Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522515. doi: 10.1093.
    PubMed     Abstract available


  216. LEON-SAMPEDRO R, Fernandez-de-Bobadilla MD, San Millan A, Baquero F, et al
    Transfer dynamics of Tn6648, a composite integrative conjugative element generated by tandem accretion of Tn5801 and Tn6647 in Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Jun 21. pii: 5521775. doi: 10.1093.
    PubMed     Abstract available


  217. SHEN P, Zhou K, Wang Y, Song J, et al
    High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    J Antimicrob Chemother. 2019 Jun 15. pii: 5519372. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  218. MORIO F, Lombardi L, Binder U, Loge C, et al
    Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491491. doi: 10.1093.
    PubMed     Abstract available


  219. REED JM, Gardner SG, Mishra NN, Bayer AS, et al
    Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 May 10. pii: 5487738. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  220. LAVERGNE RA, Morio F, Danner-Boucher I, Horeau-Langlard D, et al
    One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
    J Antimicrob Chemother. 2019 Apr 30. pii: 5481886. doi: 10.1093.
    PubMed     Abstract available


  221. PAPAGIANNITSIS CC, Tsilipounidaki K, Malli E, Petinaki E, et al
    Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
    J Antimicrob Chemother. 2019 Apr 22. pii: 5476265. doi: 10.1093.
    PubMed    


    March 2019
  222. SASSI M, Guerin F, Zouari A, Beyrouthy R, et al
    Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.
    J Antimicrob Chemother. 2019 Mar 20. pii: 5416192. doi: 10.1093.
    PubMed     Abstract available


  223. HAO W, Shan X, Li D, Schwarz S, et al
    Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396705. doi: 10.1093.
    PubMed     Abstract available


  224. HASMAN H, Clausen PTLC, Kaya H, Hansen F, et al
    LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377356. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  225. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Abstract available


  226. SINGH A, Singh PK, de Groot T, Kumar A, et al
    Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315659. doi: 10.1093.
    PubMed     Abstract available


  227. WU T, Meyer K, Harrington AT, Danziger LH, et al
    In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2019 Feb 8. pii: 5310330. doi: 10.1093.
    PubMed     Abstract available


  228. PAUL S, Singh S, Chakrabarti A, Rudramurthy SM, et al
    Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    J Antimicrob Chemother. 2019 Feb 6. pii: 5307967. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  229. KITAMURA M, Kimura K, Ido A, Seki T, et al
    Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
    J Antimicrob Chemother. 2019 Jan 11. pii: 5288581. doi: 10.1093.
    PubMed     Abstract available


  230. MORRONI G, Brenciani A, Litta-Mulondo A, Vignaroli C, et al
    Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288148. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  231. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Abstract available


  232. RYBAK JM, Fortwendel JR, Rogers PD
    Emerging threat of triazole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Dec 17. pii: 5250853. doi: 10.1093.
    PubMed     Abstract available


  233. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Abstract available


  234. AKKERMAN OW, Alffenaar JWC
    Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Dec 1. pii: 5224542. doi: 10.1093.
    PubMed    


    October 2018
  235. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: